Bio-Rad pays US$55 million to settle FCPA charges
Life science research company Bio-Rad Laboratories has agreed to pay US$55 million to settle FCPA charges brought by the US Department of Justice (DoJ) and the US Securities and Exchange Commission (SEC), the authorities announced in separate statements on Monday.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.